11 – 20 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reply to V. Nardone et al
- Contribution to journal › Debate/Note/Editorial
-
Mark
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
(2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(10). p.1849-1863
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis and Risk of Incident Lung Cancer
(2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433
- Contribution to journal › Article
-
Mark
Risk Factors for Primary Bone Cancer After Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
(2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(21). p.3735-3746
- Contribution to journal › Article
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
- Contribution to journal › Article
- 2022
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
- Contribution to journal › Article
-
Mark
Selumetinib Plus Adjuvant Radioactive Iodine in Patients with High-Risk Differentiated Thyroid Cancer : A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
- Contribution to journal › Article
- 2021
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
- Contribution to journal › Article
-
Mark
Burkitt Lymphoma International Prognostic Index
(2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(10). p.1129-1138
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
- Contribution to journal › Article
